Clindamycin enhances murine delayed-type hypersensitivity and anti-candidal activity

Area of Science:

• Immunology
• Microbiology
• Pharmacology

Background:

• Clindamycin is an antibiotic with known immunomodulatory effects.
• The impact of clindamycin on specific immune responses like contact sensitivity and fungal infections requires further elucidation.

Purpose of the Study:

• To investigate the effect of clindamycin on dinitrofluorobenzene (DNFB)-induced contact sensitivity in mice.
• To evaluate clindamycin's efficacy in modulating murine responses to experimental Candida lusitaniae infection.

Main Methods:

• Contact sensitivity was assessed using an epicutaneous painting and ear challenge assay in mice.
• Murine models of Candida lusitaniae infection were established via intravenous inoculation.
• In vitro assays examined the effect of clindamycin on macrophage phagocytic and killing activity.

Main Results:

• Clindamycin administration significantly enhanced the contact sensitivity response to DNFB.
• Optimal enhancement of DNFB sensitivity occurred when clindamycin was given concurrently with sensitization.
• Clindamycin treatment improved the clearance of Candida lusitaniae from organs in infected mice.
• In vitro, clindamycin augmented the yeast-killing capacity of murine macrophages without increasing phagocytosis.

Conclusions:

• Clindamycin potentiates specific immune responses in mice, including contact hypersensitivity and antifungal immunity.
• The findings suggest clindamycin may have broader immunomodulatory applications beyond its antimicrobial properties.